Unilabs to deploy Ibex’s AI-assisted cancer diagnostic platform across Europe

Galen by Ibex is CE-marked for breast and prostate cancer detection

Unilabs and Ibex are teaming up to make cancer diagnosis more accurate, timely, and targeted.

Per the new deal, Unilabs will deploy Ibex’s AI-powered, multi-tissue Galen platform in pathology labs across Europe. Backed by advanced machine learning algorithms, the platform evaluates tissue biopsies in real time to offer valuable insights on tumor grading and size. 

Other notable features of the Galen include worklists for case prioritization and cancer heatmaps for increased diagnostic accuracy.

"This cutting-edge AI technology will help our teams quickly prioritise urgent cases, speed up diagnosis, and improve quality by adding an extra set of digital eyes," said Dr. Christian Rebhan, chief medical and operations officer at Unilabs. 

Rebhan continued, "When it comes to cancer, the earlier you catch it, the better the prognosis – so getting us critical results faster will help save lives. The partnership with Ibex underlines Unilabs' pioneering role in digital pathology and represents yet another step in our ambition to become the most digitally enabled provider of diagnostic services in Europe."

Galen by Ibex is CE-marked for breast and prostate cancer detection. Unilabs will roll out Ibex's platform to 16 countries, starting with Sweden.

Related Resource

DevOps: A view from the enterprise

What's driving DevOps, the impact of value stream management, and more

High-rise buildings in the background of title card - whitepaper from ServiceNowDownload now

"Ibex is transforming cancer diagnosis with innovative AI solutions across the diagnostic pathway," said Joseph Mossel, chief executive officer (CEO) and co-founder of Ibex Medical Analytics. 

"We are excited to partner with Unilabs to deploy our AI solutions and empower their pathologists with faster turnaround times and quality diagnosis. This cooperation follows a thorough evaluation of our technology at Unilabs, and demonstrates the robustness and utility of our platform for everyday clinical practice."

Featured Resources

B2B under quarantine

Key B2C e-commerce features B2B need to adopt to survive

Download now

The top three IT pains of the new reality and how to solve them

Driving more resiliency with unified operations and service management

Download now

The five essentials from your endpoint security partner

Empower your MSP business to operate efficiently

Download now

How fashion retailers are redesigning their digital future

Fashion retail guide

Download now

Recommended

Alphabet tackles industrial robot software market
automation

Alphabet tackles industrial robot software market

23 Jul 2021
Preparing for AI-enabled cyber attacks
Whitepaper

Preparing for AI-enabled cyber attacks

22 Jul 2021
Telepresence medical robot market set to reach $159.5 million by 2028
automation

Telepresence medical robot market set to reach $159.5 million by 2028

19 Jul 2021
AWS launches HealthLake to help health care organizations query medical data
big data

AWS launches HealthLake to help health care organizations query medical data

16 Jul 2021

Most Popular

Salesforce's $28bn Slack acquisition: What's next for workplace collaboration?
collaboration

Salesforce's $28bn Slack acquisition: What's next for workplace collaboration?

22 Jul 2021
Samsung Galaxy S21 5G review: A rose-tinted experience
Mobile Phones

Samsung Galaxy S21 5G review: A rose-tinted experience

14 Jul 2021
One third of cyber security pros report experiencing workplace harassment
Careers & training

One third of cyber security pros report experiencing workplace harassment

22 Jul 2021